HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer

PURPOSE: The role of HHLA2, a new immune checkpoint ligand, is gradually being elucidated in various solid tumours. However, its role in ovarian cancer remains unclear; thus, its expression profile and clinical significance in ovarian cancer must be examined. METHODS: We performed immunohistochemist...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Guocai, Shi, Yuanyuan, Ling, Xiaoting, Wang, Dongyan, Liu, Yunyun, Lu, Huaiwu, Peng, Yongpai, Zhang, Bingzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106145/
https://www.ncbi.nlm.nih.gov/pubmed/33962626
http://dx.doi.org/10.1186/s12935-021-01930-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106145/
https://www.ncbi.nlm.nih.gov/pubmed/33962626
http://dx.doi.org/10.1186/s12935-021-01930-y

Ejemplares similares